ELAVL1 and triple-negative breast carcinoma: Silencing ELAVL1 directly or indirectly inhibited the growth of breast cancer in vitro and in vivo by interacting with other proteins such as β-catenin, PKD1, PKD2, and PKD3. Moreover, treatment with Quercetin in triple-negative breast cancer inhibited cytoplasmc ELAVL1, which directly affects adhesion and migration of cells (Umar et al., 2021).